Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer
Clinical trial NCT04156087 · COMPLETED
Trial details
- NCT number
- NCT04156087
- Sponsor
- Baki Topal
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-09
- Primary completion
- 2024-01-29
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.